Chong Yu to Acrylamides
This is a "connection" page, showing publications Chong Yu has written about Acrylamides.
Connection Strength
0.045
-
Outcomes in patients with non-small-cell lung cancer and acquired Thr790Met mutation treated with osimertinib: a genomic study. Lancet Respir Med. 2018 02; 6(2):107-116.
Score: 0.045
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.